RxDoctor Payments Data

Ashley Williams

Family · Martinsville, VANPI 1962032854

Payments from drug & device makers

$787in general payments, 2019–2025

Across 46 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$219
  • Lilly USA, LLC$131
  • Novo Nordisk$122
  • Exeltis, USA Inc.$62
  • Amgen$48
  • Nestle Healthcare Nutrition Inc.$35
  • plus $171 from 9 others

What the payments were for

  • Food & beverage$787100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$787 in reported general payments places this provider in the 65th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$13,910
Medicare patients
92
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide29$40,414
EliquisApixaban48$35,645
OzempicSemaglutide36$34,964
FarxigaDapagliflozin Propanediol23$17,040
XareltoRivaroxaban24$14,006
LinzessLinaclotide13$9,310
Novolog FlexpenInsulin Aspart26$4,541
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$3,126
Albuterol Sulfate HfaAlbuterol Sulfate51$1,461
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate14$1,429
Olmesartan Medoxomil12$1,375
LantusInsulin Glargine,hum.Rec.Anlog19$1,298
Metoprolol Succinate50$1,203
Pantoprazole Sodium91$1,086
Gabapentin80$1,069

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$122$75,37765 claims
PfizerEliquis$13$35,64548 claims
AbbVieLinzess$219$9,31013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,332 family providers in Virginia.

Other family in Martinsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →